Global Health Limited’s board has approved the unaudited standalone and consolidated financial results for Q3 (Oct-Dec) and nine months ended December 31, 2025. The board also approved the appointment of Mr. Malik Mohd. Ashhab as Head-Diagnostic Services and recommended the re-appointment of Dr. Ravi Gupta and Mr. Rajan Bharti Mittal as Independent Directors. Additionally, Ms. Shonan Purie Trehan was appointed as Non-Executive Non-Independent Director.
Financial Results Overview
Global Health Limited (Medanta) has announced its unaudited standalone and consolidated financial results. Key highlights from the Q3 (Oct-Dec) 2025 report:
- The Board of Directors approved these results on February 4, 2026.
- Standalone and consolidated financials show the company’s performance for the third quarter and nine months ending December 31, 2025.
Key Appointments and Re-appointments
Several key personnel decisions were made during the board meeting:
- Mr. Malik Mohd. Ashhab has been appointed as ‘Head-Diagnostic Services,’ effective February 4, 2026.
- The board recommended the re-appointment of Dr. Ravi Gupta as an Independent Director for a second term of 5 years, starting July 8, 2026, subject to shareholder approval.
- The board also recommended the re-appointment of Mr. Rajan Bharti Mittal as an Independent Director for another 5-year term, also effective July 8, 2026, pending shareholder approval.
- Ms. Shonan Purie Trehan has been appointed as a Non-Executive Non-Independent Director, liable to retire by rotation, effective March 13, 2026, subject to shareholder approval.
Standalone Financial Performance Highlights
Key figures from the standalone financial results for the quarter ended December 31, 2025:
- Total Income: ₹9,648.29 million.
- Profit Before Tax: ₹1,028.86 million.
- Profit After Tax: ₹799.07 million.
Consolidated Financial Performance Highlights
Overview of the consolidated financial results for the quarter ended December 31, 2025:
- Total Income: ₹11,428.29 million.
- Profit Before Tax: ₹1,197.83 million.
- Profit After Tax: ₹950.33 million.
The results reflect Global Health Limited’s performance in the healthcare sector, with changes in key personnel aimed at strategic growth and governance.
Source: BSE
